Using ctDNA Next-Generation Sequencing to Predict Response in Patients with Advanced NSCLC

During an interview with Targeted Oncology, Charu Agarwal, MD, reviewed the findings of a prospective study of pembrolizumab monotherapy in patients with advanced NSCLC.

QR Code
Embed the QR code on your website:
Download
Copy